Hillard M. Lazarus

Oregon Health & Science University — United States

Medicine · Health Sciences

109h-index51.8kcitations1.1kworks5.22yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Hematopoietic Stem Cell Transplantation(407), Acute Myeloid Leukemia Research(272), Acute Lymphoblastic Leukemia research(247), Lymphoma Diagnosis and Treatment(144), Chronic Lymphocytic Leukemia Research(127)

Publications1.1k total

Donor Search and Selection Strategy to Facilitate Comparable Transplant Rates across Donor Search Prognosis Groups: A Report from the BMT CTN 1702 Trial
Transplantation and Cellular Therapy·2026
Inferior survival in black AML patients treated with intensive chemotherapy in ECOG-ACRIN clinical trials is independent of cytogenetic profiles
Blood·2025Open Access
Prospective study of patient-reported depression, and cognitive and functional impairment, and impact on survival and induction mortality in fit adults age ≥60 years receiving intensive chemotherapy (IC) for Acute Myeloid Leukemia (AML): Prospective geriatric assessment (GA) report from ECOG-ACRIN (EA) E2906 randomized study
Blood·2025
Impact of therapy delays on outcomes in adults with BCR::ABL1 negative b-lineage acute lymphoblastic leukemia (ALL) in the ECOG-ACRIN E1910 trial randomized to conventional chemotherapy +/- blinatumomab
Blood·2025
Sparse whole genome sequencing and machine learning of AML genomes reveals novel, clinically relevant genetics.
Blood·2025
Bone marrow biopsy characteristics at nadir after intensive induction therapy do not predict outcomes in acute myeloid leukemia (AML): An analysis of ECOG-ACRIN clinical trials
Blood·2025
Genomic determinants of treatment outcome and identification of a new genomic subset of adult acute lymphoblastic leukemia from the ECOG-ACRIN E1910 randomized phase III trial
Blood·2025Open Access
Molecular Expression Differences in Specific Blood Mononuclear Cell‐Types Identify Patients With <scp>AL</scp> Amyloidosis
Journal of Cellular and Molecular Medicine·2025Open Access
Protein Biomarkers in Monocytes and CD4+ Lymphocytes for Predicting Lithium Treatment Response of Bipolar Disorder: a Feasibility Study with Tyramine-Based Signal- Amplified Flow Cytometry
Psychopharmacology Bulletin·2025· 16 citedOpen Access
Impact of Race and Ethnicity on Outcomes after Umbilical Cord Blood Transplantation
UNC Libraries·2025Open Access
Correction: Impact of autologous blood transfusion after bone marrow harvest on unrelated donor’s health and outcome: a CIBMTR analysis
UNC Libraries·2025Open Access
Impact of autologous blood transfusion after bone marrow harvest on unrelated donor’s health and outcome: a CIBMTR analysis
UNC Libraries·2025Open Access
Signalling Network Analysis of Blood Mononuclear Cells From Clinical Samples by Bivariate Correlation
Journal of Cellular and Molecular Medicine·2025Open Access
POS0005 Inhaled Pirfenidone as an innovative therapeutic approach to treat autoimmune ILD and other forms of Progressive Pulmonary Fibrosis: Phase 2b Study Design
Annals of the Rheumatic Diseases·2025Open Access
Efficacy of Total‐Body Irradiation‐based Intensified Myeloablative Regimens for Acute Leukemia—An International Collaborative Study
eJHaem·2025Open Access
Cytokines in hematology, hematopoietic cell transplantation and immune effector cell therapy: Preface
Best Practice & Research Clinical Haematology·2025
Dose-Dependent Change of Inhaled Pirfenidone Seen in Lung Volume and Fibrosis Quantification in Patients With IPF: A Deep Learning Image-Based Analysis of Data from the ATLAS Phase 1b Trial
American Journal of Respiratory and Critical Care Medicine·2025
Long-term Safety and Efficacy Data With Inhaled Pirfenidone (AP01) in the Atlas Open-label Extension Study Up to 240 Weeks
American Journal of Respiratory and Critical Care Medicine·2025· 1 cited
Abstract 7128: Neoantigen expression and expansion of cytotoxic T cell clonotypes in multiple myeloma patients receiving a personalized cancer vaccine post-transplant: Insights from the BM CTN 1401 multicenter trial
Cancer Research·2025
Delayed T-cell recovery after hematopoietic cell transplantation is associated with decreased overall survival in adults
Blood Advances·2025· 1 citedOpen Access
page 1 of 53Next →

Frequent Co-authors

Mark R. Litzow(13), Martin S. Tallman(13), Robert Peter Gale(13), David I. Marks(13), Selina M. Luger(12), Jacob M. Rowe(10), Mary M. Horowitz(10), Philip L. McCarthy(9), Elisabeth Paietta(8), Richard T. Maziarz(8), Armand Keating(6), Christopher Bredeson(6), John P. Klein(6), César O. Freytes(6), David A. Rizzieri(5), Mitchell S. Cairo(5), Adele K. Fielding(5), Susan Richards(5), Georgina Buck(5), Andrew McMillan(5)